Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in MDD Patients With Suboptimal Early Response to Antidepressants
NCT06692361Recruiting
- Start
- Jan 2025
- Primary completion
- Jun 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial of FMT Capsule DE in major depressive disorder (MDD) (2 arms). Primary endpoint: Hamilton Depression Rating Scale 17-item score reduction rate >= 50% at 8 weeks. Started Jan 2025; status: recruiting.
02
Drugs
FMT Capsule DE
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06692361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06692361.